STATE OF WISCONSIN INVESTMENT BOARD - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,017,540
-25.9%
56,593
-4.1%
0.01%
-25.0%
Q2 2023$2,722,177
+10.5%
59,011
-4.0%
0.01%
+14.3%
Q1 2023$2,464,225
-20.4%
61,452
-8.0%
0.01%
-30.0%
Q4 2022$3,094,612
+10.8%
66,795
-0.9%
0.01%
+11.1%
Q3 2022$2,792,000
-33.4%
67,414
-4.0%
0.01%
-18.2%
Q2 2022$4,192,000
-1.0%
70,257
+20.5%
0.01%
+22.2%
Q1 2022$4,235,000
+533.0%
58,311
+633.3%
0.01%
+800.0%
Q4 2021$669,000
-8.2%
7,952
-1.6%
0.00%
-50.0%
Q3 2021$729,000
-0.7%
8,078
+5.0%
0.00%0.0%
Q2 2021$734,000
-92.5%
7,696
-91.0%
0.00%
-90.5%
Q1 2021$9,735,000
-19.2%
85,500
-1.7%
0.02%
-25.0%
Q4 2020$12,043,000
+61.0%
87,000
-4.4%
0.03%
+47.4%
Q3 2020$7,479,000
+5.1%
91,0000.0%0.02%
-5.0%
Q2 2020$7,118,000
+90.1%
91,000
+7.9%
0.02%
+66.7%
Q1 2020$3,745,000
+7.3%
84,300
+3.2%
0.01%
+33.3%
Q4 2019$3,489,000
-0.2%
81,7000.0%0.01%
-10.0%
Q3 2019$3,495,000
-28.0%
81,700
+6.9%
0.01%
-28.6%
Q2 2019$4,851,000
+5.5%
76,400
+15.2%
0.01%
+7.7%
Q1 2019$4,599,000
+118.6%
66,300
+37.0%
0.01%
+85.7%
Q4 2018$2,104,000
-43.5%
48,400
-0.8%
0.01%
-30.0%
Q3 2018$3,725,000
-0.7%
48,8000.0%0.01%
-9.1%
Q2 2018$3,751,000
+81.9%
48,800
+20.7%
0.01%
+83.3%
Q1 2018$2,062,000
+9.9%
40,4450.0%0.01%
+20.0%
Q4 2017$1,876,000
-12.9%
40,4450.0%0.01%
-16.7%
Q3 2017$2,154,000
+23.9%
40,445
+44.4%
0.01%0.0%
Q2 2017$1,739,00028,0000.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders